KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Return on Capital Employed (2016 - 2026)

Fulgent Genetics' Return on Capital Employed history spans 11 years, with the latest figure at 6.41% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 14.0% to 6.41% in Q1 2026 year-over-year; TTM through Mar 2026 was 6.41%, a 14.0% decrease, with the full-year FY2025 number at 1.3%, up 510.0% from a year prior.
  • Return on Capital Employed hit 6.41% in Q1 2026 for Fulgent Genetics, down from 4.9% in the prior quarter.
  • Over the last five years, Return on Capital Employed for FLGT hit a ceiling of 49.65% in Q1 2022 and a floor of 18.02% in Q3 2024.
  • Historically, Return on Capital Employed has averaged 2.16% across 5 years, with a median of 6.26% in 2025.
  • Biggest five-year swings in Return on Capital Employed: plummeted -5132bps in 2023 and later soared 1177bps in 2025.
  • Tracing FLGT's Return on Capital Employed over 5 years: stood at 32.64% in 2022, then crashed by -149bps to 15.98% in 2023, then soared by 60bps to 6.41% in 2024, then rose by 23bps to 4.9% in 2025, then plummeted by -31bps to 6.41% in 2026.
  • Business Quant data shows Return on Capital Employed for FLGT at 6.41% in Q1 2026, 4.9% in Q4 2025, and 6.26% in Q3 2025.